4-122827149-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000264498.9(FGF2):c.374G>A(p.Gly125Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,385,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000264498.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGF2 | NM_001361665.2 | c.-26G>A | 5_prime_UTR_variant | 1/3 | ENST00000644866.2 | NP_001348594.1 | ||
FGF2 | NM_002006.6 | c.374G>A | p.Gly125Glu | missense_variant | 1/3 | NP_001997.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGF2 | ENST00000264498.9 | c.374G>A | p.Gly125Glu | missense_variant | 1/3 | 1 | ENSP00000264498 | |||
FGF2 | ENST00000644866.2 | c.-26G>A | 5_prime_UTR_variant | 1/3 | NM_001361665.2 | ENSP00000494222 | P1 | |||
FGF2 | ENST00000608478.1 | c.-26G>A | 5_prime_UTR_variant | 1/3 | 1 | ENSP00000477134 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000467 AC: 7AN: 149756Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000190 AC: 1AN: 52628Hom.: 0 AF XY: 0.0000329 AC XY: 1AN XY: 30382
GnomAD4 exome AF: 0.000127 AC: 157AN: 1235942Hom.: 0 Cov.: 32 AF XY: 0.000105 AC XY: 63AN XY: 601166
GnomAD4 genome AF: 0.0000467 AC: 7AN: 149862Hom.: 0 Cov.: 31 AF XY: 0.0000137 AC XY: 1AN XY: 73074
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.374G>A (p.G125E) alteration is located in exon 1 (coding exon 1) of the FGF2 gene. This alteration results from a G to A substitution at nucleotide position 374, causing the glycine (G) at amino acid position 125 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at